Statistics for Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications
Total visits
| views | |
|---|---|
| Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications | 153 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| fgene-11-00349.pdf | 89 |
| java.util.UUID:d66ba509-1bc1-4c44-af26-6d13702d84ac | 41 |
| java.util.UUID:d6f7e81e-9362-4a18-8ad3-0dba7fc0223b | 7 |
| java.util.UUID:3c195768-daae-45b6-baca-46bca32b5693 | 6 |
Top country views
| views | |
|---|---|
| United States | 105 |
| Germany | 8 |
| Ukraine | 3 |
| China | 2 |
| Russia | 2 |
| Vietnam | 2 |
| Argentina | 1 |
| Canada | 1 |
| Switzerland | 1 |
| Czechia | 1 |
| United Kingdom | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Romania | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 47 |
| Fairfield | 13 |
| Cambridge | 7 |
| Houston | 6 |
| Jacksonville | 5 |
| Ann Arbor | 4 |
| Kiez | 4 |
| San Francisco | 4 |
| Baltimore | 3 |
| Gunzenhausen | 3 |
| Kiev | 3 |
| Dong Ket | 2 |
| Kansas City | 2 |
| Moscow | 2 |
| Whiteland | 2 |
| Beijing | 1 |
| Chicago | 1 |
| Frankfurt Am Main | 1 |
| Geneva | 1 |
| Islamabad | 1 |
| Kuala Lumpur | 1 |
| Laurel | 1 |
| Petrosani | 1 |
| Slapanice | 1 |
| Stockholm | 1 |
| Toronto | 1 |
| Zhongyuan | 1 |